Cargando…
Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?
Pulmonary arterial hypertension (PAH) is a condition of unknown etiology whose pathological features include increased vascular resistance, perivascular inflammatory cell infiltration and pulmonary arteriolar remodeling. Although risk factors for PAH are poorly defined, recent studies indicate that...
Autores principales: | Summer, Ross, Walsh, Kenneth, Medoff, Benjamin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329073/ https://www.ncbi.nlm.nih.gov/pubmed/22530098 http://dx.doi.org/10.4103/2045-8932.93542 |
Ejemplares similares
-
Pulmonary Hypertension and Obesity: Focus on Adiponectin
por: Perrotta, Fabio, et al.
Publicado: (2019) -
Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity
por: Zhou, Yuanyuan, et al.
Publicado: (2021) -
Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening
por: Liu, Shao-Fei, et al.
Publicado: (2022) -
Pediatric Obesity and Vitamin D Deficiency: A Proteomic Approach Identifies Multimeric Adiponectin as a Key Link between These Conditions
por: Walker, Gillian E., et al.
Publicado: (2014) -
Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2021)